首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿立哌唑与利培酮治疗精神分裂症研究
引用本文:冀德才,于彩霞,孙月吉,黄敏,黄清.阿立哌唑与利培酮治疗精神分裂症研究[J].临床精神医学杂志,2007,17(4):261-262.
作者姓名:冀德才  于彩霞  孙月吉  黄敏  黄清
作者单位:1. 大连医科大学
2. 132011,吉林市精神病医院
摘    要:目的:评价阿立哌唑治疗精神分裂症的疗效及不良反应。方法:64例精神分裂症患者,随机分为两组,分别给予阿立哌唑与利培酮治疗8周。采用阳性与阴性症状量表(PANSS)、治疗中出现的症状量表(TESS)评定疗效及不良反应。结果:阿立哌唑组显效率为78.1%,利培酮组为75.0%。利培酮组锥体外系反应稍高于阿立哌唑组。结论:阿立哌唑与利培酮疗效相似,锥体外系反应比利培酮少,是一种有效、安全的抗精神病药物。

关 键 词:阿立哌唑  利培酮  精神分裂症
文章编号:1005-3220(2007)04-0261-02
收稿时间:2006-10-13
修稿时间:2006年10月13

A study of aripiprazole and risperidone in treatment of schizophrenia
JI De-cai,YU Cai-xia,SUN Yue-ji,HUANG Min,HUANG Qing.A study of aripiprazole and risperidone in treatment of schizophrenia[J].Journal of Clinical Psychological Medicine,2007,17(4):261-262.
Authors:JI De-cai  YU Cai-xia  SUN Yue-ji  HUANG Min  HUANG Qing
Institution:Jilin Mental Hospital, Jilin 132011, China
Abstract:Objective:To observe the adverse events and efficacy of aripiprazole in the treatment of schizophrenia.Method:Sixty-four cases of schizophrenia were randomly divided into aripiprazole group and risperidone group.The course of treatments was 8 weeks.The therapeutic effects were evaluated by positive and negative symptom scale(PANSS),and side effects were assessed by treatment emergent symptom scale(TESS).Results:The rates of marked improvement in aripiprazole group and risperidone group were 78.1% and 75.0% respectively.The extracorticospinal(EPS) tract reaction was more severe in risperidone group than in aripiprazole group.Conclusion:Aripiprazole,as well as risperidone,is one of effective antipsychotics and less EPS in the treatment of schizophrenia.
Keywords:aripiprazole  risperidone  schizophrenia
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号